Evaluation of the VIA® blood chemistry monitor for glucose in healthy and diabetic volunteers

Journal of Diabetes Science and Technology

Volumn 2, Issue 2, 2008, Pages 182-193

  Ganesh, Arjunan ^a   Hipszer, Brian ^b   Loomba, Navdeep ^c   Simon, Barbara ^d   Torjman, Marc C ^e   Joseph, Jeffrey ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c Universal Pain Management   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e Department of Anesthesiology   (United States)

Author keywords

CGM; Continuous glucose monitoring system; Glucose sensor; V GLU1 glucose sensor; VIA blood chemistry monitor for glucose; VIA glucose monitoring system

Indexed keywords

EID: 60349129607     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680800200203     Document Type: Conference Paper

References (89)

1. Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of the critically ill? Diabetologia.. 2006;49(8):1722-5.
2. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures.. Ann Thorac Surg. 1999;67(2):352-60; discussion 360-2.
3. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2007;35(10):2262-7.
4. Van Den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359-67.
5. Van Den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P. Outcome beneft of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.. Crit Care Med. 2003;31(2):359-66.
6. Van Den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006 Feb. 2;354(5):449-61.
7. Levetan CS, Salas JR, Wilets IF, Zumoff B. Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes.. Am J Med. 1995;99(1):22-8.
8. Levetan CS, Magee MF. Hospital management of diabetes. Endocrinol Metab Clin North Am. 2000;29(4):745-70.
9. Top 50 drug products associated with medication errors [homepage on the Internet]. Rockville, MD: United States Pharmacopeia [cited 2007 Nov]. Available from: http://www.usp.org/hqi/patientSafety/resources/top50DrugErrors.html.
10. Blake DR, Nathan DM. Point-of-care testing for diabetes. Crit Care Nurs Q. 2004;27(2):150-61.
11. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, Hirsch IB; American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27(2):553-91.
12. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting.. J Thorac Cardiovasc Surg. 2003;125(5):1007-21.
13. Ellmerer M, Haluzik M, Blaha J, Kremen J, Svacina S, Toller W, Mader J, Schaupp L, Plank J, Pieber T. Clinical evaluation of alternative-site glucose measurements in patients after major cardiac surgery.. Diabetes Care. 2006;29(6):1275-81.
14. Atkin SH, Dasmahapatra A, Jaker MA, Chorost MI, Reddy S. Fingerstick glucose determination in shock. Ann Intern Med. 1991;114(12):1020-4.
15. Kulkarni A, Saxena M, Price G, O'Leary MJ, Jacques T, Myburgh JA. Analysis of blood glucose measurements using capillary and arterial blood samples in intensive care patients.. Intensive Care Med. 2005;31(1):142-5.
16. Ray JG, Hamielec C, Mastracci T. Pilot study of the accuracy of bedside glucometry in the intensive care unit. Crit Care Med. 2001;29(11):2205-7.
17. Sylvain HF, Pokorny ME, English SM, Benson NH, Whitley TW, Ferenczy CJ, Harrison JG. Accuracy of fngerstick glucose values in shock patients. Am J Crit Care. 1995;4(1):44-8.
18. Kanji S, Buffe J, Hutton B, Bunting PS, Singh A, McDonald K, Fergusson D, McIntyre LA, Hebert PC. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005;33(12):2778-85.
19. Kagel EM, Rayan GM. Intravenous catheter complications in the hand and forearm. J Trauma. 2004;56(1):123-7.
20. Mohler M, Sato Y, Bobick K, Wise LC. The reliability of blood sampling from peripheral intravenous infusion lines. Complete blood cell counts, electrolyte panels, and survey panels. J Intraven Nurs. 1998;21(4):209-14.
21. Seemann S, Reinhardt A. Blood sample collection from a peripheral catheter system compared with phlebotomy. J Intraven Nurs. 2000;23(5):290-7.
22. Becan-McBride K. Laboratory sampling. Does the process affect the outcome? J Intraven Nurs. 1999;22(3):137-42.
23. Kuwa K, Nakayama T, Hoshino T, Tominaga M. Relationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma.. Clin Chim Acta. 2001;307(1-2):187-92.
24. Yucha CB, De Angelo E. The minimum discard volume: accurate analysis of peripheral hematocrit. J Intraven Nurs. 1996;19(3):141-6.
25. O'Hare D, Chilvers RJ. Arterial blood sampling practices in intensive care units in england and wales. Anaesthesia. 2001;56(6):568-71.
26. Flood J, Joseph J, Kim L, McNulty S, Chervoneva I. Glucose levels in blood simultaneously sampled from the radial artery, vena cava, and fngertip. Anesthesiology. 2007;107:A1123.
27. Joseph J. Anesthesia and surgery in the diabetic patient. In: Goldstein BJ, Muller-Wieland D, editors. Textbook of type 2 diabetes. Informa Healthcare; 2003. p. 393-408.
28. American diabetes association: Clinical practice recommendations 1996. Diabetes Care. 1996;19Suppl 1:S1-118.
29. Requirements for in vitro blood glucose monitoring systems for self-testing in managing diabetes mellitus.. ISO/TC 212/WG 3. In: Draft International Standard ISO/DIS 15197. ISO 2001 ed. Geneva, Switzerland: International Organization for Standardization.
30. Lacara T, Domagtoy C, Lickliter D, Quattrocchi K, Snipes L, Kuszaj J, Prasnikar M. Comparison of point-of-care and laboratory glucose analysis in critically ill patients. Am J Crit Care. 2007;16(4):336-46; quiz 347.
31. Mann EA, Pidcoke HF, Salinas J, Wade CE, Holcomb JB, Wolf SE. Accuracy of glucometers should not be assumed. Am J Crit Care. 2007;16(6):531-2; author reply 532.
32. Kost GJ, Vu HT, Lee JH, Bourgeois P, Kiechle FL, Martin C, Miller SS, Okorodudu AO, Podczasy JJ, Webster R, Whitlow KJ. Multicenter study of oxygen-insensitive handheld glucose pointof-care testing in critical care/hospital/ambulatory patients in the united states and canada.. Crit Care Med. 1998;26(3):581-90.
33. Bochicchio GV, Sung J, Joshi M, Bochicchio K, Johnson SB, Meyer W, Scalea TM. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma. 2005;58(5):921-4.
34. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.. Lancet. 2000;355(9206):773-8.
35. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290(15):2041-7.
36. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes.. Diabetes Care. 1999;22(9):1408-14.
37. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.. Mayo Clin Proc. 2003;78(12):1471-8.
38. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients.. Mayo Clin Proc. 2004;79(8):992-1000.
39. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events.. Circulation. 2004;109(12):1497-502.
40. Malmberg K, Rydén L, Efendic S, Herlitz J, Nicol P, Waldenström A, Wedel H, Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year.. J Am Coll Cardiol. 1995;26(1):57-65.
41. Ouattara A, Lecomte P, Le Manach Y, Landi M, Jacqueminet S, Platonov I, Bonnet N, Riou B, Coriat P. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients.. Anesthesiology. 2005;103(4):687-94.
42. Pomposelli JJ, Baxter JK 3rd, Babineau TJ, Pomfret EA, Driscoll DF, Forse RA, Bistrian BR. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr. 1998;22(2):77-81.
43. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.. J Clin Endocrinol Metab. 2002;87(3):978-82.
44. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63(2):356-61.
45. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105(2):244-52.
46. Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications.. 2005;19(3):178-81.
47. Braithwaite SS, Buie MM, Thompson CL, Baldwin DF, Oertel MD, Robertson BA, Mehrotra HP. Hospital hypoglycemia: not only treatment but also prevention. Endocr Pract. 2004;10Suppl 2:89-99.
48. Devos P, Preiser JC. Is it time for implementation of tight glycaemia control by intensive insulin therapy in every ICU? Crit Care.. 2006;10(2):130.
49. Devos P, Preiser JC. Current controversies around tight glucose control in critically ill patients. Curr Opin Clin Nutr Metab Care. 2007;10(2):206-9.
50. Fischer KF, Lees JA, Newman JH. Hypoglycemia in hospitalized patients. causes and outcomes. N Engl J Med. 1986;315(20):1245-50.
51. GluControl study: Comparing the effects of two glucose control regimens by insulin in intensive care unit patients [homepage on the Internet]. U. S. National Institutes of Health [cited 2 2007 Nov]. Available from: http://clinicaltrials.gov/show/NCT00107601.
52. Mitchell I, Finfer S, Bellomo R, Higlett T, ANZICS Clinical Trials Group Glucose Management Investigators. Management of blood glucose in the critically ill in Australia and New Zealand: a practice survey and inception cohort study.. Intensive Care Med. 2006 Jun; 32(6):867-74.
53. Stagnaro-Green A, Barton MK, Linekin PL, Corkery E, De Beer K. Roman SH. Mortality in hospitalized patients with hypoglycemia and severe hyperglycemia. Mt Sinai J Med. 1995;62(6):422-6.
54. Thomas AN, Boxall EM, Twamley HW. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med. 2007;35(4):1218-9; author reply 1219.
55. A multi-centre, open label randomised stratifed controlled trial of the effects of blood glucose management on 9 90-day all-cause mortality in a heterogeneous population of intensive care unit (ICU) patients [homepage on the Internet]. BioMed Central [cited 2007 Nov]. Available from: http://controlled- trials.com/ISRCTN04968275/ISRCTN04968275.
56. Vriesendorp TM, De Vries JH, Van Santen S, Moeniralam HS, De Jonge E, Roos YB, Schultz MJ, Rosendaal FR, Hoekstra JB. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med. 2006;34(11):2714-8.
57. Wexler DJ, Meigs JB, Cagliero E, Nathan DM, Grant RW. Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U. S.. hospitals. Diabetes Care. 2007;30(2):367-9.
58. Zander R, Boldt J, Engelmann L, Mertzlufft F, Sirtl C, Stuttmann R. The design of the VISEP trial. Critical appraisal. Anaesthesist. 2007;56(1):71-7.
59. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffer M, Reinhart K; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125-39.
60. Kagansky N, Levy S, Rimon E, Cojocaru L, Fridman A, Ozer Z, Knobler H. Hypoglycemia as a predictor of mortality in hospitalized elderly patients. Arch Intern Med. 2003;163(15):1825-9.
61. Taylor BE, Schallom ME, Sona CS, Buchman TG, Boyle WA, Mazuski JE, Schuerer DE, Thomas JM, Kaiser C, Huey WY, Ward MR, Zack JE, Coopersmith CM. Efficacy and safety of an insulin infusion protocol in a surgical ICU. J Am Coll Surg. 2006;202(1):1-9.
62. Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control.. Am J Crit Care. 2006;15(4):370-7.
63. Bailey PL, McJames SW, Cluff ML, Wells DT, Orr JA, Westenskow DR, Kern SE. Evaluation in volunteers of the VIA V-ABG automated bedside blood gas, chemistry, and hematocrit monitor.. J Clin Monit Comput. 1998;14(5):339-46.
64. Baloga JM, Edelman SV. Use of a real-time glucose sensor (VIA model 121) for glucose clamp studies (#519). Diabetes. 1996;45(Suppl 2):142A.
65. Lucisano JY, Edelman SV, Quinto BD, Wong DK. Development of a biosensor-based, patient-attached blood glucose monitoring system. Proc Am Chem Soc. 1997;76:256.
66. VIA blood chemistry monitor for glucose VIA V-GLU 1 operator's manual. San Diego, CA: VIA Medical Corporation; 1998.
67. HemoCue operator's manual. Angelholm, Sweden: HemoCue AB; 2000.
68. Torjman MC, Jahn L, Joseph JI, Crothall K. Accuracy of the hemocue portable glucose analyzer in a large nonhomogeneous population. Diabetes Technol Ther. 2001;3(4):591-600.
69. Voss EM, Cembrowski GS. Performance characteristics of the HemoCue B-glucose analyzer using whole-blood samples. Arch Pathol Lab Med. 1993;117(7):711-3.
70. Hipszer B, Joseph J, Kam M. Pharmacokinetics of intravenous insulin delivery in humans with type 1 diabetes. Diabetes Technol Ther. 2005;7(1):83-93.
71. IFCC recommendation on reporting results for blood glucose. Clinica Chim Acta. 2001;307(1-2):205-9.
72. Fogh-Andersen N, D'Orazio P. Proposal for standardizing directreading biosensors for blood glucose. Clin Chem. 1998;44(3):655-9.
73. Bland JM, Altman DG. Measurement error and correlation coefficients. BMJ. 1996;313(7048):41-2.
74. Widness JA, Kulhavy JC, Johnson KJ, Cress GA, Kromer IJ, Acarregui MJ, Feld RD. Clinical performance of an in-line point-oficare monitor in neonates. Pediatrics. 2000;106(3):497-504.
75. Coss-Bu JA, Jefferson LS, Stone-McCord S, Ou CN, Watrin C, Sachdeva R, Copeland KC. Evaluation of a real-time blood glucose monitor in children with diabetic ketoacidosis. Diabetes Res Clin Pract. 1999;44(3):175-81.
76. Cousins TR, O'Donnell JM. Arterial cannulation: a critical review. AANA J. 2004;72(4):267-71.
77. Martin C, Saux P, Papazian L, Gouin F. Long-term arterial cannulation in ICU patients using the radial artery or dorsalis pedis artery. Chest. 2001;119(3):901-6.
78. Wallach SG. Cannulation injury of the radial artery: diagnosis and treatment algorithm. Am J Crit Care. 2004;13(4):315-9.
79. Hoste EA, Roels NR, Decruyenaere JM, Colardyn FA. Significant increase of activated partial thromboplastin time by heparinization of the radial artery catheter fush solution with a closed arterial catheter system.. Crit Care Med. 2002;30(5):1030-4.
80. Lew JK, Hutchinson R, Lin ES. Intra-arterial blood sampling for clotting studies. Effects of heparin contamination. Anaesthesia. 1991;46(9):719-21.
81. Adverse event report: VIA Medical Corp. glucose sensor [homepage on the Internet]. U. S. Food and Drug Administration [cited 2007 Nov]. Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/Detail. CFM?MDRFOI-ID=136092.
82. Dahlberg M, Whitelaw A. Evaluation of HemoCue blood glucose analyzer for the instant diagnosis of hypoglycaemia in newborns.. Scand J Clin Lab Invest. 1997;57(8):719-24.
83. Ashworth L, Gibb I, Alberti KG. HemoCue: evaluation of a portable photometric system for determining glucose in whole blood. Clin Chem. 1992;38(8Pt 1):1479-82.
84. Burrin JM, Alberti KG. What is blood glucose: can it be measured? Diabet Med. 1990;7(3):199-206.
85. Elimam A, Horal M, Bergstrom M, Marcus C. Diagnosis of hypoglycaemia: effects of blood sample handling and evaluation of a glucose photometer in the low glucose range.. Acta Paediatr. 1997;86(5):474-8.
86. M'Bemba J, Chevalier A, Bruzzo F, Slama G, Selam JL. Usefulness of the hemocue blood glucose photometer in hypoglycaemic conditions. Diabet Med. 1997;14(8):711.
87. Rassam AG, Mcleod J, Burge MR, Schade DS. Use of the HemoCue blood glucose analyzer in research studies. Diabetes Care. 1998;21(8):1369-70.
88. Wiener K. An assessment of the effect of haematocrit on the HemoCue blood glucose analyser. Ann Clin Biochem. 1993;30(Pt 1):90-3.
89. Young RP, Critchley JA, Lau MS, Lee KK, Robertshaw AM, Chan TY, Anderson DC. Reliability of glucose measurement using the HemoCue analyser in hypoglycaemia. Ann Clin Biochem. 1994;31(Pt 6):573-5.